Shattuck Labs (STTK) Other Working Capital Changes (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Other Working Capital Changes of -$1.1 million for Q1 2026, down 6625.0% year-over-year from $16490.4 in Q1 2025, and up 37.7% quarter-over-quarter from -$1.7 million in Q4 2025.
Powered by 
Analysis
Shattuck Labs (STTK) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Other Working Capital Changes for 8 consecutive years, with -$225000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 6625.0% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$2.9 million (up 40.7% YoY), while the FY2025 annual figure was -$1.8 million, up 71.45% from the prior year.
- Other Working Capital Changes advanced to -$225000.0 in Q1 2026 per STTK's latest filing, from -$278000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $800000.0 in Q2 2023 and bottomed at -$1.3 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$221562.5 across 5 years, with a median of -$223000.0 in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 337.39% in 2023 and fell as far as 638.89% in 2023.
- Shattuck Labs' Other Working Capital Changes stood at -$34000.0 in 2022, then soared by 4311.76% to $1.4 million in 2023, then sank by 539.59% to -$6.3 million in 2024, then jumped by 72.57% to -$1.7 million in 2025, then surged by 37.7% to -$1.1 million in 2026.
- Business Quant data shows STTK's Other Working Capital Changes at -$225000.0 in Q1 2026, -$278000.0 in Q4 2025, and -$644000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | -1.08 Mn |
| Mar 31, 2026 | -1.08 Mn |
| Dec 31, 2025 | -180,000.00 |
| Dec 31, 2025 | -180,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | -1.30 Mn |
| Jun 30, 2025 | -1.30 Mn |
| Mar 31, 2025 | -723,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Dec 31, 2024 | -2.45 Mn |
| Dec 31, 2024 | -2.45 Mn |
| Sep 30, 2024 | -399,000.00 |
| Sep 30, 2024 | -399,000.00 |
| Jun 30, 2024 | -8.89 Mn |
| Jun 30, 2024 | -8.89 Mn |
| Mar 31, 2024 | 5.38 Mn |
| Mar 31, 2024 | 5.38 Mn |